Cantor Fitzgerald, L. P. Neuro Sense Therapeutics Ltd. Call Options Transaction History
Cantor Fitzgerald, L. P.
- $1.04 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
8Shares Held
225KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X046KShares$42,7760.0% of portfolio
-
Meitav Dash Investments LTD40KShares$37,2000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$31,8800.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$11,7410.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$11,1250.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $10.9M